RTI Surgical® Showcases Advancements in Spine Portfolio and Clinical Data at NASS 2019
Summary
CHICAGO, Sept. 25, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, will showcase its expanding portfolio and body of clinical data to reinforce the growing strength of its spine business at the North American Spine Society’s (NASS) 34th Annual Meeting in Chicago, September 25-28. Among the key findings, the analysis of patients treated with the Fortilink IBF Systems demonstrated the device is safe and results in improvements in pain. SImmetry® System Lab featured in NASS After Hours: SI-Joint Hands-On Workshop On Wednesday, September 25, RTI Surgical will participate in the “NASS After Hours: SI-Joint Hands-On Workshop.” This NASS-sponsored program includes a didactic session (3:30-5 p.m.) followed by a hands-on lab (5-8 p.m.) to review the current state of SI joint dysfunction and the various ways surgeons treat this condition, including the SImmetry® Sacroiliac Joint Fusion System. Committed to delivering a higher standard, RTI’s implants are used in spine, sports medicine, general surgery, orthopedic and trauma procedures and are distributed in nearly 50 countries. Additional information about issues that could lead to material changes in performance is contained in the company’s annual and quarterly reports filed with the Securities and Exchange Commission.
Classifications
AskAI Classifications
LabelsLinked Companies
